Predictors to Intravenous Fluid Responsiveness

Journal of Intensive Care Medicine
Jorge Iván Alvarado SánchezManuel Ignacio Monge García

Abstract

Management with intravenous fluids can improve cardiac output in some surgical patients. Management with static preload indicators, such as central venous pressure and pulmonary artery occlusion pressure, has not demonstrated a suitable relationship with changes in the cardiac output induced by intravenous fluid therapy. Dynamic indicators, such as the variability of arterial pulse pressure or stroke volume variation, have demonstrated a suitable relationship. Since improvement in cardiac output does not guarantee an adequate perfusion pressure, in patients with hypotension, it is also necessary to know whether arterial pressure will also increase with intravenous fluid therapy. In this regard, the functional assessment of arterial load by dynamic arterial elastance could help to determine which patients will improve not only their cardiac output but also their mean arterial pressure.

References

Nov 1, 1978·Southern Medical Journal·J J Rick, S S Burke
Jan 1, 1976·Acta Anaesthesiologica Scandinavica·T BrundinG McCarthy
Nov 1, 1992·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·J JueN B Schiller
Jul 1, 1992·Archives of Surgery·L N DiebelR A Kline
Sep 1, 1966·Anesthesiology·B C MorganW G Guntheroth
Aug 1, 1983·Circulation·F JardinJ P Bourdarias
Apr 1, 1994·Cardiovascular Research·J N Amoore, W P Santamore
Oct 1, 1995·Journal of Cardiothoracic and Vascular Anesthesia·M BeaussierP Viars
Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·B ValtierD M Payen
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·F MichardJ L Teboul
Jun 12, 1999·British Journal of Anaesthesia·M ShamirR Pizov
Jul 21, 2000·American Journal of Respiratory and Critical Care Medicine·F MichardJ L Teboul
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Feb 14, 2002·Journal of Applied Physiology·Paul C M van den BergMichael R Pinsky
Jun 18, 2002·Chest·Frédéric Michard, Jean-Louis Teboul
Apr 10, 2003·Intensive Care Medicine·Margareta RoeckJukka Takala
Jun 1, 1957·The American Journal of Physiology·A C GUYTONT RICHARDSON
Jun 1, 1963·Circulation Research·A G WALLACES J SARNOFF
Dec 9, 2003·Journal of Applied Physiology·Karim BendjelidJacques A Romand
Mar 27, 2004·Intensive Care Medicine·Marc FeisselJean-Louis Teboul
Apr 20, 2004·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Management Guidelines Committee
Sep 3, 2004·Critical Care Medicine·Steven M HollenbergSergio Zanotti-Cavazzoni
Sep 18, 2004·Intensive Care Medicine·Antoine Vieillard-BaronFrançois Jardin
Oct 8, 2004·Critical Care : the Official Journal of the Critical Care Forum·Luciano GattinoniFranco Valenza
Mar 9, 2005·Intensive Care Medicine·Daniel De BackerJean-Louis Vincent
Mar 17, 2005·British Journal of Anaesthesia·H BerkenstadtA Perel
Jun 2, 2005·Current Opinion in Critical Care·Sheldon Magder

❮ Previous
Next ❯

Citations

Jul 2, 2019·Journal of Pharmacy Practice·W Anthony HawkinsTrisha N Branan
Feb 13, 2020·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·Jorge Iván Alvarado SánchezLuis Eduardo Cruz Martínez
Dec 2, 2020·Critical Care Nurse·Ashley BarlowAmber E King
Sep 4, 2021·Journal of Clinical Monitoring and Computing·Taner AbdullahMukadder Orhan Sungur

❮ Previous
Next ❯

Software Mentioned

Eadyn

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.